AbbVie Inc. (4AB.DE) XETRA

195.60

+2.2(+1.14%)

Updated at December 23 05:35PM

Currency In EUR

Valuation

Market Cap310.82B
Enterprise Value372.44B
P/E Ratio170.16
PEG Ratio-4.6
Price/Sales Ratio6.81
Price/Book Ratio-154.19
Enterprise/Revenue7.87
Enterprise/EBITDA36.89

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterSeptember 30, 2025

Profitability

Profit Margin0.04
Operating Margin0.22

Management Effectiveness

Return On Assets0.02
Return On Equity4.99

Income Statement

Revenue56.33B
Revenue/Share33.66
Gross Profit39.43B
EBITDA14.91B
Net Income4.28B
Diluted EPS2.39

Balance Sheet

Total Cash5.67B
Total Cash/Share3.2
Total Debt68.74B
Total Debt/Equity-26.02
Current Ratio0.72
Book Value Per Share-1.47

Price History

52-Week Change14.41
52-Week High207
52-Week Low147.6
Moving Average 50 Days194.62
Moving Average 200 Days178.06

Statistics

Average Volume415
Shares Outstanding1.77B
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate6.56
Trailing Annual Dividend Yield2.85
Payout Ratio4.8
Last Split FactorN/A
Last Split DateN/A